TGA Approval

ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack (281022)

ARTG ID

281022

ARTG Name

ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack

Sponsor

Lupin Australia Pty Limited

ARTG Date

October 6, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Lupin Australia Pty Limited

Sponsor Item Name

LUPIN AUSTRALIA PTY LIMITED

Active Ingredients

Ingredient Name

lamivudine

Ingredient Name

abacavir hydrochloride monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack (281022) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack (281022)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal